The Low Molecular Weight Heparin (LMWH) Market is gaining significant attention as healthcare providers increasingly focus on preventing and treating thromboembolic disorders, including deep vein thrombosis and pulmonary embolism.
Market Overview
The low molecular weight heparin market is expected to grow from US$ 3,658.27 million in 2021 to US$ 5,733.96 million by 2028; it is estimated to grow...
